Study | Exclusion reasons | Remarks | Reference(s) | ||
---|---|---|---|---|---|
HYDRA, 2020 | randomized controlled trial | Initially found in Axfors et al. meta-analysis results published by Hernadez et al | |||
CloroCOVID19, 2020 | randomized controlled trial | inadequate or absent control group | This paper reports partial results from an unplanned interim analysis.Efficacy and safety criteria do not appear to have ever been assessed on the same number of patients (denominators are different for almost every criterion and are less than the number of patients randomized). Compared to the registration record, the patient eligibility criteria were changed. |
Borba JAMA Netw Open 2020; 3:e208857 10.1001/jamanetworkopen.2020.8857 Mayla Borba for CloroCovid-19 Team medRxiv 2020.04.07.20056424 |
|
Ye et al., 2020 | observational study | not relevant study design |
Ye Eur Rev Med Pharmacol Sci 2020; 24:3390-3396 10.26355/eurrev_202003_20706 |
||
ChiCTR2000029975, 0 | single-arm | not relevant study design | |||
Duke university (Hydroxychloroquine), 2020 | randomized controlled trial | cancelled by investigator | |||
Duke University azithromycin, 2020 | randomized controlled trial | cancelled by investigator | Discontinuated : Poor recruitment, strong evidence from larger trials of no therapeutic benefit | ||
ChiCTR2000029826 (Cancelled by the investigator), 0 | randomized controlled trial | cancelled by investigator | |||
SIMPLE (Grein), 0 | single-arm | no control group | single-arm with external control group |
Grein N. Engl. J. Med. 2020; 382:2327-2336 10.1056/NEJMoa2007016 |
|
Erdem, 2020 | retrospective cohort (registry) | no control group | |||
Hazan, 2021 | case series | no control group |
Hazan S et al. medrxiv;2021.07.06.21259924v1 10.1101/2021.07.06.21259924 |
||
Yamamura, 2020 | single-arm | no control group |
Yamamura H Crit Care 2020 Jul 9;24(1):413. 10.1186/s13054-020-03137-5 |
||
Hazan, 2021 | case series | no control group |
Hazan S et al. medrxiv;2021.07.06.21259924v1 10.1101/2021.07.06.21259924 |
||
Murohashi, 2020 | prospective cohort | no control group |
Murohashi K Respir Investig 2020 Aug 28;58(6):430-434. 10.1016/j.resinv.2020.08.001 |
||
Nasir, 2020 | non randomized controlled trial | no clinically relevant endpoint | |||
Thakar, 2021 | randomized controlled trial | no clinically relevant endpoint |
Thakar A Indian J Med Res 2021 Jan 21. 10.4103/ijmr.IJMR_3665_20 |
||
Dabbous, 2021 | randomized controlled trial | other | Withdrawal of the publication. |
Dabbous HM Arch Virol 2021 Jan 25;1-6. 10.1007/s00705-021-04956-9 |
|
IFORS (Pott-Junior), 2020 | randomized controlled trial | other | The article has been retracted by Toxicology Reports |
Pott-Junior H Toxicol Rep 2021;8:505-510. 10.1016/j.toxrep.2021.03.003 |
|
Elgazzar - treatment, 2020 | randomized controlled trial | other | withdrawal of the publication | ||
Barbosa, 2020 | retrospective cohort | other | the only document variable for this study is a copy of a submission to NEJM. It is impossible to verify the veracity of this document. The paper was submitted apr 4th and since this date ther is no publication in NEJM or in other media (included preprint server). | ||
Mallat, 2020 | retrospective cohort | other | inapropriate statistical analysis. Time to events analyszed with means without taken into account the censure due to death or lost to follow-up |
Jihad Mallat, Fadi Hamed, Maher Balkis, Mohamed A Mohamed, Mohamad Mooty, Asim Malik, Ahmad Nusair, Fernanda Bonilla medRxiv 2020.04.27.20082180 10.1101/2020.04.27.20082180 |
|
Mehra, 2020 | retrospective cohort | other | the paper was retracted by 3 authors on June 4, 2020 |
Mehra MR Lancet 2020 May 22;S0140-6736(20)31180-6. 10.1016/S0140-6736(20)31180-6 Mehra MR Lancet 2020 Jun 13;395(10240):1820. 10.1016/S0140-6736(20)31324-6 |
|
Niaee (vs placebo), 2020 | randomized controlled trial | other | On 8 October 2021 and 9 October 2021, two articles were published by subject-matter experts outlining concerns about various aspects of the study and, in particular, calling into question the randomization of participants. The authors and publishing journal have been alerted to these issues, and this note will be updated with any new information related to the publication. |
Niaee MS et al. researchsquare 10.21203/rs.3.rs-109670/v1 Niaee MS et al. Asian Pacific Journal of Tropical Medicine 10.4103/1995-7645.318304 |
|
Mehra, 2020 | retrospective cohort | other | the paper was retracted by 3 authors on June 4, 2020 |
Mehra MR Lancet 2020 May 22;S0140-6736(20)31180-6. 10.1016/S0140-6736(20)31180-6 Mehra MR Lancet 2020 Jun 13;395(10240):1820. 10.1016/S0140-6736(20)31324-6 |
|
Cadegiani -Iver, 2020 | observational study | other | unappropriated control group |
Cadegiani FA medrxiv https://doi.org/10.1101/2020.10.31.20223883 |